Skip to content

NVS

Novartis AG

NYSE · Healthcare · Drug Manufacturers - General · CH

$164.60
+3.35%
Ask drillr

Margins

Gross margin
74.6%
EBITDA margin
38.7%
EBIT margin
25.5%
Net margin
17.8%
FCF margin
26.4%
27.0%
Return on equity
8.6%
Return on assets
16.8%
Return on invested capital
0.47x
Asset turnover
$17.3B
Cash from operations
$4.75
Cash per share

Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026